Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06150976 · ClinicalTrials.gov registry record · NA
MAAT For Young Adult Cancer Survivors
A NA study, sponsored by University of Pittsburgh.
- Completed
- Registry status
- NA
- Development phase
- 7
- Enrollment target
NCT06150976 is a NA study that has completed, run by University of Pittsburgh. The registered enrollment target is 7 participants.
The verdict
NCT06150976, a NA study, has completed, sponsored by University of Pittsburgh.
- COMPLETED
- Registry status
- NA
- Development phase
- 7 participants
- Enrollment target
Study Summary
The goal of this clinical trial is to pilot-test a modified version of telehealth-delivered Memory and Attention Adaption Training (MAAT) that is tailored to young adult childhood cancer survivors (ages 18-39; MAAT-YS) with cancer-related cognitive impairment (CRCI). MAAT-YS consists of 8 weekly visits (45-minutes in duration) and participants use a survivor workbook and complete homework between visits. Participants in this single-group pilot trial (N=9) will complete online self-report measures of cognitive symptoms, quality of life, treatment satisfaction and a brief online neuropsychological test battery at baseline and post-MAAT-YS timepoints.
Interventions
- BEHAVIORAL MAAT-YS
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 7 participants |
| Start Date | 2025-02-12 |
| Est. Completion | 2025-09-05 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT06150976
The ClinicalTrials.gov registry entry for NCT06150976 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 7 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of Pittsburgh, which has 1,238 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which MAAT-YS is the first listed.
NCT06150976 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT06150976 about?
NCT06150976 is a clinical study titled "MAAT For Young Adult Cancer Survivors". The goal of this clinical trial is to pilot-test a modified version of telehealth-delivered Memory and Attention Adaption Training (MAAT) that is tailored to young adult childhood cancer survivors (ages 18-39; MAAT-YS) with cancer-related cognitive impairment (CRCI). MAAT-YS consists of 8 weekly vis...
What is the current status of trial NCT06150976?
This trial is currently completed. It is a NA study. The enrollment target is 7 participants. The study started on 2025-02-12. Estimated completion is 2025-09-05.
What interventions are being tested in trial NCT06150976?
The interventions under investigation include: MAAT-YS (BEHAVIORAL).
Who is sponsoring clinical trial NCT06150976?
This trial is sponsored by University of Pittsburgh, which has 1,238 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.